UFP Technologies Inc (UFPT) FinancialsUFPTFinancialUFP Technologies Inc

UFP Technologies Inc (UFPT) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Product, accounting for 97.9% of total sales, equivalent to $145.10M. Other significant revenue streams include Engineering And Development and Tooling And Machinery. Understanding this composition is critical for investors evaluating how UFPT navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, UFP Technologies Inc maintains a gross margin of 29.27%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 16.19%, while the net margin is 11.99%. These profitability ratios, combined with a Return on Equity (ROE) of 17.05%, provide a clear picture of how effectively UFPT converts its operational activities into shareholder value.

In the context of the broader market, UFPT competes directly with industry leaders such as OLN and FUL. With a market capitalization of $2.32B, it holds a significant position in the sector. When comparing efficiency, UFPT's gross margin of 29.27% stands against OLN's 10.10% and FUL's 33.68%. Such benchmarking helps identify whether UFP Technologies Inc is trading at a premium or discount relative to its financial performance.

UFP Technologies reported Q2 2026 sales of $174 million, a 15.1% year-over-year increase, with net income rising to $20.9 million, showcasing strong demand in the MedTech sector.